Literature DB >> 22851873

Multiple esophageal variceal ruptures with massive ascites due to myelofibrosis-induced portal hypertension.

Koichi Tokai1, Hiroyuki Miyatani, Yukio Yoshida, Shigeki Yamada.   

Abstract

A 75-year old man had been diagnosed at 42 years of age as having polycythemia vera and had been monitored at another hospital. Progression of anemia had been recognized at about age 70, and the patient was thus referred to our center in 2008 where secondary myelofibrosis was diagnosed based on bone marrow biopsy findings. Hematemesis due to rupture of esophageal varices occurred in January and February of 2011. The bleeding was stopped by endoscopic variceal ligation. Furthermore, in March of the same year, hematemesis recurred and the patient was transported to our center. He was in irreversible hemorrhagic shock and died. The autopsy showed severe bone marrow fibrosis with mainly argyrophilic fibers, an observation consistent with myelofibrosis. The liver weighed 1856 g the spleen 1572 g, indicating marked hepatosplenomegaly. The liver and spleen both showed extramedullary hemopoiesis. Myelofibrosis is often complicated by portal hypertension and is occasionally associated with gastrointestinal hemorrhage due to esophageal varices. A patient diagnosed as having myelofibrosis needs to be screened for esophageal/gastric varices. Myelofibrosis has a poor prognosis. Therefore, it is necessary to carefully decide the therapeutic strategy in consideration of the patient's concomitant conditions, treatment invasiveness and quality of life.

Entities:  

Keywords:  Myelofibrosis; Portal hypertension; Rupture of esophageal varices

Mesh:

Year:  2012        PMID: 22851873      PMCID: PMC3406433          DOI: 10.3748/wjg.v18.i28.3770

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

1.  Portal hypertension in myeloid metaplasia. Report of a case without apparent portal obstruction.

Authors:  N OISHI; S N SWISHER; J M STORMONT; S I SCHWARTZ
Journal:  Arch Surg       Date:  1960-07

2.  Management of polycythemia vera and essential thrombocythemia.

Authors:  Peter J Campbell; Anthony R Green
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

3.  Portal hypertension complicating myelofibrosis: reversal following splenectomy.

Authors:  B E Lukie; R T Card
Journal:  Can Med Assoc J       Date:  1977-10-08       Impact factor: 8.262

4.  Esophageal varices in agnogenic myeloid metaplasia: disappearance after splenectomy. A case report.

Authors:  A Sullivan; H Rheinlander; L R Weintraub
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

5.  Spleen blood flow and splanchnic haemodynamics in blood dyscrasia and other splenomegalies.

Authors:  L M Blendis; D C Banks; C Ramboer; R Williams
Journal:  Clin Sci       Date:  1970-01       Impact factor: 6.124

Review 6.  The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.

Authors:  H P Ward; M H Block
Journal:  Medicine (Baltimore)       Date:  1971-09       Impact factor: 1.889

7.  Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia.

Authors: 
Journal:  Ann Intern Med       Date:  1995-11-01       Impact factor: 25.391

8.  Portal hypertension in the myeloproliferative syndrome and the reticuloses.

Authors:  S SHALDON; S SHERLOCK
Journal:  Am J Med       Date:  1962-05       Impact factor: 4.965

  8 in total
  1 in total

1.  Myelofibrosis and Portal Hypertension: The Case for Primary Variceal Screening.

Authors:  Marc Samuel Sherman; Wesley R Samore; Daniel Stephan Pratt
Journal:  ACG Case Rep J       Date:  2020-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.